At Avanzia Pharma, we specialize in designing tailored strategies to meet the needs of companies seeking innovative solutions, often not accommodated by more traditional laboratories’ business plans. Our main goal is to maximize the value of these products, providing growth opportunities and visibility in the market.
One of our primary focuses is to add value to the patient. We are committed to marketing high-quality and trusted medications, ensuring their effectiveness and safety. We work through a rigorous product selection process, making sure to offer therapeutic options that enhance the quality of life for patients.
At Avanzia Pharma, we are dedicated to promoting innovation in the pharmaceutical sector, driving access to cutting-edge treatments, and contributing to the advancement of medicine in Latin America. Our commitment to excellence and our passion for improving people’s health guide us in every step we take.
Our vision, is to lead and direct the market in the commercialization of innovative pharmaceutical products
OUR VALUES
INTEGRITY: At Avanzia Pharma, we adhere to fundamental principles of reliability, truth, and capability. We believe in the importance of being a trustworthy partner, providing truthful information, and fulfilling our commitments. We strive to deliver solid and quality results, meeting the needs of our clients and business partners.
COMMITMENT: At Avanzia Pharma, we give our best to achieve agreed-upon results with our partners and clients. We focus on setting clear goals and achieving outcomes, keeping our promises. We demonstrate personal involvement in every project and relationship, working with determination and dedication to achieve success.
INNOVATION: We embrace challenges and are willing to step out of our comfort zone in pursuit of excellence. We dare to take calculated risks for the sake of innovation and growth. We demonstrate courage in decision-making and face obstacles with determination.
COLLABORATION: Avanzia Pharma establishes strong and lasting relationships with all stakeholders in the healthcare ecosystem to add value. In today’s globalized business environment, we believe in collaborative work with the best to ensure the achievement of our objectives.
FLEXIBILITY: We respond quickly to changes in the market because reality always exceeds our expectations, and threats can become opportunities. We win in the face of uncertainty with decisiveness and Swift análisis.
PRESENCE avanzia pharma
São Paulo - BRASIL
Av. Brigadeiro Faria Lima, 3729 (5º Andar)
Tlf: +55 (11) 34436200
Santiago - CHILE
Av. Andrés Bello, 2687
Tlf: +56 226664314
Quito - ECUADOR
Av. Diego de Almagro, 32-27 (Ed Whymper)
Tlf: +593 43716799
Bella Vista - PANAMÁ
C. 50 Calle 53 (Ed Plaza 2000)
Tlf: +507 2804700
San Rafael Escazú (San José) - COSTA RICA
CC Plaza Roble Las Terrazas
Tlf: +506 22011565
Bogotá - COLOMBIA
Calle 95 #14-45
Tlf: +57 1 6672566
Miami (Florida) - EEUU
801 Brickell Av.
Tlf: +1 3059132400
La Libertad - EL SALVADOR
Urb. Madre Selva III, 313 (Ed Avante)
Tegucigalpa - HONDURAS
Col. La Estancia, 304 (T. Consortium I)
Managua - NICARAGUA
Ant. Hospital Militar, 1 (Ed Consortium Legal)
Cdad de Guatemala - GUATEMALA
Vía 5, 5-34 (Torre III)
Cdad de México - MÉXICO
Av. Chapultepec, 480 (Roma Nte)
Tlf: +52 1 5531181910
San Isidro - PERÚ
C. Las Orquídeas, 585 (Ed Fibra)
Tlf: +51 7125975
St Port of Spain - TRINIDAD Y TOBAGO
113 Oxford Street (Altus Court)
Santo Domingo - REPÚBLICA DOMINICANA
C. Rafael Augusto Sánchez, 86 (Roble CC)
Tlf: +1 8097925072
Kingston - JAMAICA
21 East Street
Algés - PORTUGAL
Rua D. António Ribeiro, 1
Tlf: +351 214135480
Las Rozas de Madrid (Madrid) - ESPAÑA
C. Valle de Alcudia, 1-3
Tlf: +34 902106447
Barcelona - ESPAÑA
Moll de Barcelona (World Trade Center)
OUR HistorY
2017
Inicio de actividades en España como laboratorio comercializador bajo la marca Zaltanpharma Laboratories.
Products in Cardiology and Rheumatology.
2018
Expansion of the portfolio in Pain, Oncology, and Urology.
2019
Venta de la filial Española a Riemser GmbH (compañía de Ardian, mayor gestor de fondos de Europa)
2022
Rebranding and establishment of Avanzia Pharma Laboratories in Spain.
Opening of subsidiaries in Mexico and Central America.
.
2023
New contracts in Spain, Mexico, and Central America.
Portfolio in CNS, Oncology, Pain, and Respiratory.
Launch of Digital Therapies.
Opening of subsidiaries in Colombia and Brazil.
EXECUTIVE COMMITTEE
Carlos Díez-Ruza
MANAGEMENT TEAM
Enrique Remezal
MANAGEMENT TEAM
Mercedes López de Riquer
MANAGEMENT TEAM